Adding More SNPs to Breast Cancer Risk Models Doesn't Help | GenomeWeb

In the New England Journal of Medicine, researchers from the National Cancer Institute say breast cancer risk assessment models don't perform any better when they include common inherited genetic variants linked to the disease. The study's senior investigator, Sholom Wacholder, says the improvement in the risk models wasn't enough to matter to a majority of women. Wacholder and his team combined data from five studies, altogether including 5,590 breast cancer patients and 5,998 healthy women.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.